Literature DB >> 23458586

Different definitions of prevalent hypertension impact: the clinical epidemiology of hypertension and attainment of Healthy People goals.

Brent M Egan1, Yumin Zhao.   

Abstract

Prevalent hypertension in National Health and Nutrition Examination Surveys (NHANES) is traditionally defined as blood pressure (BP) ≥140 mm Hg systolic and/or ≥90 diastolic and/or currently taking antihypertensive medications. When estimating prevalent hypertension, American Heart Association (AHA) statistical updates include the traditional definition of hypertension (tHTN) and untreated individuals with nonhypertensive BP told twice that they were hypertensive (nontraditional [ntHTN]). The characteristics of ntHTN and their impact on the clinical epidemiology of hypertension and Healthy People prevention and control goals are undefined. NHANES 1999-2002, 2003-2006, and 2007-2010 were analyzed. The ntHTN group was younger and had less diabetes and lower BP than the tHTN group but higher BP than the normotensive group. When classifying ntHTN as hypertensive, prevalent hypertension increased approximately 3% and control 5% to 6% across NHANES periods. In 2007-2010, the Healthy People 2010 goal of controlling BP in 50% of all hypertensive patientss was attained when ntHTN was classified as hypertension (56.5% [95% confidence interval (CI), 54.2-58.7]) and nonhypertension (51.8% [95% CI, 49.6-53.9]). When including ntHTN in prevalent hypertension estimates, the Healthy People 2020 goal of controlling BP in 60% of hypertensive patients becomes more attainable, whereas reducing prevalent hypertension to 26.9% (31.8% [95% CI, 30.5-33.1]) vs 28.7% [95% CI, 27.5-30.0]) becomes more challenging.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23458586      PMCID: PMC3589732          DOI: 10.1111/jch.12057

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  25 in total

Review 1.  The burden of blood pressure-related disease: a neglected priority for global health.

Authors:  Vlado Perkovic; Rachel Huxley; Yangfeng Wu; Dorairaj Prabhakaran; Stephen MacMahon
Journal:  Hypertension       Date:  2007-10-22       Impact factor: 10.190

2.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

Authors: 
Journal:  Diabetes Care       Date:  1997-07       Impact factor: 19.112

3.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

4.  Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004.

Authors:  Kwok Leung Ong; Bernard M Y Cheung; Yu Bun Man; Chu Pak Lau; Karen S L Lam
Journal:  Hypertension       Date:  2006-12-11       Impact factor: 10.190

5.  The burden of adult hypertension in the United States 1999 to 2000: a rising tide.

Authors:  Larry E Fields; Vicki L Burt; Jeffery A Cutler; Jeffrey Hughes; Edward J Roccella; Paul Sorlie
Journal:  Hypertension       Date:  2004-08-23       Impact factor: 10.190

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

7.  Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

Authors:  Ihab Hajjar; Theodore A Kotchen
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

8.  Vital signs: awareness and treatment of uncontrolled hypertension among adults--United States, 2003-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-09-07       Impact factor: 17.586

9.  Impact of the number of blood pressure measurements on blood pressure classification in US adults: NHANES 1999-2008.

Authors:  Joel Handler; Yumin Zhao; Brent M Egan
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-10-22       Impact factor: 3.738

10.  Different definitions of prevalent hypertension impact: the clinical epidemiology of hypertension and attainment of Healthy People goals.

Authors:  Brent M Egan; Yumin Zhao
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-12-26       Impact factor: 3.738

View more
  15 in total

1.  Implementing programs to improve hypertension management in typical practice settings: not as easy as it sounds.

Authors:  Jeff Whittle
Journal:  Am J Hypertens       Date:  2013-12-21       Impact factor: 2.689

2.  Differences and similarities in explanatory models of hypertension in the United States of america, Tanzania and Jamaica.

Authors:  J D Purakal; J Williams-Johnson; E W Williams; S Pemba; J Kambona; R Welch; J Flack; P Levy
Journal:  West Indian Med J       Date:  2014-06-11       Impact factor: 0.171

3.  Effectiveness of a tailored behavioral intervention to improve hypertension control.

Authors:  Brent M Egan
Journal:  Hypertension       Date:  2014-11-17       Impact factor: 10.190

Review 4.  Anxiety and Hypertension: Is There a Link? A Literature Review of the Comorbidity Relationship Between Anxiety and Hypertension.

Authors:  Heather M Johnson
Journal:  Curr Hypertens Rep       Date:  2019-07-18       Impact factor: 5.369

5.  Null mutation of the nicotinamide adenine dinucleotide phosphate-oxidase subunit p67phox protects the Dahl-S rat from salt-induced reductions in medullary blood flow and glomerular filtration rate.

Authors:  Louise C Evans; Robert P Ryan; Elizabeth Broadway; Meredith M Skelton; Theresa Kurth; Allen W Cowley
Journal:  Hypertension       Date:  2014-12-08       Impact factor: 10.190

6.  Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network.

Authors:  Brent M Egan; Yumin Zhao; Jiexiang Li; W Adam Brzezinski; Thomas M Todoran; Robert D Brook; David A Calhoun
Journal:  Hypertension       Date:  2013-08-05       Impact factor: 10.190

7.  Closing the gap in hypertension control between younger and older adults: National Health and Nutrition Examination Survey (NHANES) 1988 to 2010.

Authors:  Brent M Egan; Jiexiang Li; Ibrahim F Shatat; J Michael Fuller; Angelo Sinopoli
Journal:  Circulation       Date:  2014-04-14       Impact factor: 29.690

8.  Risk of Cardiovascular Disease Related to Smoking Is Greater Among Women With Sleep-Disordered Breathing.

Authors:  Lucas M Donovan; Laura C Feemster; Martha E Billings; Laura J Spece; Matthew F Griffith; Peter J Rise; Elizabeth C Parsons; Brian N Palen; Daniel J O'Hearn; Susan Redline; David H Au; Vishesh K Kapur
Journal:  J Clin Sleep Med       Date:  2018-11-15       Impact factor: 4.062

9.  Influenza vaccine and cardiac protection: a study from a tertiary care center.

Authors:  Umayya Musharrafieh; Jad Dergham; Carla Daou; Hani Tamim; Rana Houry; Abdul Rahman Bizri
Journal:  Hum Vaccin Immunother       Date:  2019-11-14       Impact factor: 3.452

10.  Blood Pressure Control Provides Less Cardiovascular Protection in Adults With Than Without Apparent Treatment-Resistant Hypertension.

Authors:  Brent M Egan; Bo Kai; C Shaun Wagner; Joseph H Henderson; Archie H Chandler; Angelo Sinopoli
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-02-09       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.